Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-03-29

FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

The FDA approved a supplemental application for albuterol sulfate from Chartwell RX, LLC., updating an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol sulfate (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE (ALBUTEROL SULFATE)